NaCl 3% Bolus Therapy as Emergency Treatment for Severe Hyponatremia: Comparison of 100 mL vs 250 mL

被引:2
|
作者
Massop, Karen [1 ,2 ]
Haverkort, Dieneke A. [1 ]
Bech, Anneke P. [1 ]
de Boer, Hans [1 ]
机构
[1] Rijnstate Hosp Arnhem, Dept Internal Med, Wagnerlaan 55, NL-6815 AD Arnhem, Netherlands
[2] Rijnstate Hosp Arnhem, Interne Geneeskunde, Wagnerlaan 55, NL-6815 AD Arnhem, Netherlands
关键词
hyponatremia; emergency; treatment; hypertonic saline; HYPERTONIC SALINE; SYMPTOMATIC HYPONATREMIA; RAPID CORRECTION; RISK-FACTORS; MORTALITY; PROTOCOL; SODIUM;
D O I
10.1210/clinem/dgad080
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context The aim of initial treatment of severe hyponatremia is to rapidly increase serum sodium to reduce the complications of cerebral edema. The optimal strategy to achieve this goal safely is still under debate. Objective To compare the efficacy and safety of 100 and 250 mL NaCl 3% rapid bolus therapy as initial treatment of severe hypotonic hyponatremia. Methods Retrospective analysis of patients admitted to a teaching hospital in The Netherlands between 2017 and 2019. The patients were 130 adults with severe hypotonic hyponatremia, defined as serum sodium <= 120 mmol/L. A bolus of either 100 mL (n = 63) or 250 mL (n = 67) NaCl 3% was the initial treatment. Successful treatment was defined as a rise in serum sodium >= 5 mmol/L within the first 4 hours after bolus therapy. Overcorrection of serum sodium was defined as an increase of more than 10 mmol/L in the first 24 hours. Results The percentage of patients with a rise in serum sodium >= 5 mmol/L within 4 hours was 32% and 52% after a bolus of 100 and 250 mL, respectively (P = .018). Overcorrection of serum sodium was observed after a median of 13 hours (range 9-17 hours) in 21% of patients in both treatment groups (P = .971). Osmotic demyelination syndrome did not occur. Conclusion Initial treatment of severe hypotonic hyponatremia is more effective with a NaCl 3% bolus of 250 mL than of 100 mL and does not increase the risk of overcorrection.
引用
收藏
页码:e521 / e526
页数:6
相关论文
共 5 条
  • [1] Retrospective evaluation of 3% NaCl treatment in patients with symptomatic hyponatremia in the emergency department
    Ozcete, Enver
    Arslan, Bahadir
    ANNALS OF CLINICAL AND ANALYTICAL MEDICINE, 2023, 14 (10): : 873 - 878
  • [2] Protocolized proactive desmopressin plus 3% saline therapy for severe euvolemic hyponatremia in the wave of COVID-19: The local experience and the potential role of emergency departments
    Cheung, Jonathan Chun-Hei
    Cheung, Emmanuel Hei-Lok
    Ho, Laptin
    Tse, Chiu Lun
    Yip, Yu-Yeung
    Lam, Koon Ngai
    HONG KONG JOURNAL OF EMERGENCY MEDICINE, 2023, 30 (06) : 447 - 452
  • [3] Comparison of morning basal+1 bolus insulin therapy (insulin glulisine plus insulin glargine 300 U/mL vs insulin lispro plus insulin glargine biosimilar) using continuous glucose monitoring: A randomized crossover study
    Takeishi, Soichi
    Tsuboi, Hiroki
    Takekoshi, Shodo
    JOURNAL OF DIABETES INVESTIGATION, 2018, 9 (01): : 91 - 99
  • [4] Long-standing prophylactic therapy vs. episodic treatment in young people with severe haemophilia: a comparison of age-matched Danish and Russian patients
    Ingerslev, J.
    Lethagen, S.
    Poulsen, L. Hvitfeldt
    Sorensen, B.
    Lopatina, E.
    Tentsova, I.
    Yastrubinetskaya, O.
    Plyushch, O. P.
    HAEMOPHILIA, 2014, 20 (01) : 58 - 64
  • [5] Changes over time in creatinine clearance and comparison of emergent adverse events for HIV-positive adults receiving standard doses (300 mg/day) of lamivudine-containing antiretroviral therapy with baseline creatinine clearance of 30-49 vs ≥50 mL/min
    Ross, Lisa L.
    Walker, A. Sarah
    Lou, Yu
    Tenorio, Allan R.
    Gibb, Diana M.
    Double, Julia
    Gilks, Charles
    McCoig, Cynthia C.
    Munderi, Paula
    Musoro, Godfrey
    Kityo, Cissy M.
    Grosskurth, Heiner
    Hakim, James
    Mugyenyi, Peter N.
    Cutrell, Amy
    Perger, Teodora
    Shaefer, Mark S.
    PLOS ONE, 2019, 14 (11):